OptimizeRx OPRX Debt - Unamortized Discount (Premium) and Issuance Costs, Net
Debt - Unamortized Discount (Premium) and Issuance Costs, Net at other companies
Other financials
Where this comes from
Reported directly by OptimizeRx in its filing.
Tagged under the XBRL concept us-gaap:UnamortizedDebtIssuanceExpense.
The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about OptimizeRx's debt - unamortized discount (premium) and issuance costs, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OptimizeRx's debt - unamortized discount (premium) and issuance costs, net?
- OptimizeRx (OPRX) reported debt - unamortized discount (premium) and issuance costs, net of $255K in Q1 2026.
- How has OptimizeRx's debt - unamortized discount (premium) and issuance costs, net changed year-over-year?
- OptimizeRx's debt - unamortized discount (premium) and issuance costs, net decreased by 80.4% year-over-year, from $1.3M to $255K.
- What is the long-term trend for OptimizeRx's debt - unamortized discount (premium) and issuance costs, net?
- Over 2 years (2023 to 2025), OptimizeRx's debt - unamortized discount (premium) and issuance costs, net has grown at a -45.4% compound annual growth rate (CAGR), from $2.06M to $614K.
- What does debt - unamortized discount (premium) and issuance costs, net mean?
- This represents the net adjustment to the face value of debt, accounting for original issue discounts, premiums, and capitalized debt issuance costs. These amounts are amortized over the life of the debt instrument to reflect the effective interest rate. It is essential for reconciling the carrying value of debt to its face value.